We are live on ! Find out more
APVO icon

Aptevo Therapeutics
APVO

1 hedge funds and large institutions have $42.1M invested in Aptevo Therapeutics in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

36% less capital invested

Capital invested by funds: $65.5M → $42.1M (-$23.5M)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
KCM
Kennedy Capital Management
Missouri
-$4.22M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3.12M
3
AFM
Anson Funds Management
Texas
-$798K
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$404K
5
Verition Fund Management
Verition Fund Management
Connecticut
-$336K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
1
Tang Capital Management
California
$27.2M – – –
RI
2
RTW Investments
New York
$4.34M – – –
TCM
3
Towercrest Capital Management
Pennsylvania
$3.26M – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$2.21M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.09M – – –
BlackRock
6
BlackRock
New York
$856K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$616K – – –
Northern Trust
8
Northern Trust
Illinois
$351K – – –
Franklin Resources
9
Franklin Resources
California
$242K – – –
BFM
10
Boothbay Fund Management
New York
$237K – – –
GCP
11
GSA Capital Partners
United Kingdom
$211K – – –
Morgan Stanley
12
Morgan Stanley
New York
$170K – – –
State Street
13
State Street
Massachusetts
$169K – – –
JC
14
JBF Capital
Colorado
$60K – – –
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$25K – – –
Wells Fargo
16
Wells Fargo
California
$24K – – –
TRCT
17
Tower Research Capital (TRC)
New York
$18K – – –
Fifth Third Bancorp
18
Fifth Third Bancorp
Ohio
$4K – – –
IA
19
IFP Advisors
Florida
$3K – – –
PNC Financial Services Group
20
PNC Financial Services Group
Pennsylvania
$2K – – –
TC
21
Truvestments Capital
Florida
$1K – – –
Alyeska Investment Group
22
Alyeska Investment Group
Illinois
– -$3.12M – –
AFM
23
Anson Funds Management
Texas
– -$798K – –
Balyasny Asset Management
24
Balyasny Asset Management
Illinois
– -$404K – –
DTL
25
Dynamic Technology Lab
Singapore
– -$315K – –
1
2

APVO Hedge Fund Activity: Q3 2021 in Review

1 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Aptevo Therapeutics (APVO) for Q3 2021, worth a combined $42.1M — down 36% from $65.5M a quarter earlier.

Fund positioning in APVO was balanced in Q3 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Kennedy Capital Management, cutting an estimated $4.22M.

  • 1 institutional investor held Aptevo Therapeutics (APVO) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $42.1M of Aptevo Therapeutics stock for Q3 2021, down 36% quarter-over-quarter.
  • 0 funds opened new Aptevo Therapeutics positions in Q3 2021 and 0 closed out.
  • The largest Aptevo Therapeutics seller in Q3 2021 was Kennedy Capital Management, an estimated $4.22M sold.

Based on aggregated 13F filings for Q3 2021.